TCT 2009 schedule

Revision as of 13:46, 7 August 2009 by Kogando (talk | contribs)
Jump to navigation Jump to search

Here is the page we will use to coordinate the TV events at TCT 2009.



Click on Date for Detailed Schedule

Sunday September 20, 2009

Monday September 21, 2009

Tuesday September 22, 2009

Wednesday September 23, 2009

Thursday September 24, 2009

Friday September 25, 2009


Sunday September 20, 2009

Return to top

Monday September 21, 2009

1:00 PM

1:05 PM - 1:15 PM

  • Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
  • Room: 104

1:51 PM - 2:03 PM

  • Event: The Drug-Eluting Stent Summit Part 1: Appropriate Utilization of Current Generation Devices. Session III. DES Safety Considerations
  • Room: 104

Return to top

Tuesday September 22, 2009

10:00 AM

10:00 AM - 12:00 PM

  • Event: Oral Abstracts- AMI
  • Room: 125

Return to top

Wednesday September 23, 2009

12:45 PM

12:45 PM - 12:50 PM

  • Event: Open Issues I: Adjunct Pharmacology. Schedule
  • Room: 130

1:35 PM

1:35 PM - 1:45 PM

  • Event: Open Issues I: Adjunct Pharmacology. Schedule
  • Room: 130

4:00 PM

4:00 PM - 4:45 PM

  • Event: Main Arena I. Plenary Session #7 Personalized Clinical Decision-Making Case Study: The Ischemia vs. Bleeding Controversy
  • Room: Esplanade Ballroom

Return to top

Thursday September 24, 2009

8:45 AM

8:46 AM - 11:11 AM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 2: Current Choices in Antithrombin Therapy for ACS and PCI
  • Room: 135

11:45 PM

11:45 AM - 11:57 AM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
  • Room: 135

12:09 PM

12:09 PM - 12:24 PM

  • Event: Antithrombin Alternatives: Low Molecular Weight Heparins, Direct Anti-Thrombins, Xa Inhibitors and Emerging Agents. Session 3: Emerging Alternatives for Antiocoagulation for ACS and PCI
  • Room: 135

5:02 PM

5:02 PM - 5:14 PM

  • Event: Balancing Safety and Efficacy of Antithrombotic Therapies for PCI and ACS. Antiplatelet Agents, Bleeding, and Ischemia
  • Room: 135

Return to top

Friday September 25, 2009

2:24 PM

2:24 PM - 2:36 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

GPIIb/IIIa Inhibitors in ACS: EARLY ACS

  • Room: EBM and Guidelines Theater, Hall D

2:36 PM

2:36 PM - 3:12 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

Aspirin and Clopiodgrel in ACS: CURRENT-OASIS 7

  • Room: EBM and Guidelines Theater, Hall D

3:00 PM

3:00 PM - 3:12 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

Aspirin and Clopiodgrel in ACS: CURRENT-OASIS 7

  • Room: EBM and Guidelines Theater, Hall D

3:24 PM

3:24 PM - 3:36 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

Ticagrelor in ACS: PLATO

  • Room: EBM and Guidelines Theater, Hall D

3:36 PM

3:36 PM - 3:48 PM

  • Event: Top Interventional Trials of the Last Year: Perspectives from the Experts

Ticagrelor in ACS: PLATO

  • Room: EBM and Guidelines Theater, Hall D

Return to top